足三里穴位注射地塞米松治疗恶性肿瘤化疗后骨髓抑制的观察护理(1)
 |
| 第1页 |
参见附件。
中图分类号:R245.9+5
文献标识码: A
文章编号: 1672-3783(2009)-10-0004-02
【摘 要】目的 观察足三里穴位注射地塞米松治疗恶性肿瘤化疗所致骨髓抑制的疗效及不良反应。方法 将112例中、晚期恶性肿瘤化疗后发生骨髓抑制白细胞减少的患者随机分成两组,55例采用足三里穴位注射地塞米松治疗,57例以重组人粒细胞集落刺激因子皮下注射作为对照组。观察白细胞恢复情况及两组的不良反应。结果 两组患者白细胞恢复时间及效果无统计学意义(P﹥0.05)。不良反应:穴位注射组,1例患者感局部胀痛明显,未能坚持治疗,余无特殊不良反应。对照组2例出现全身酸痛、1例低热、1例骨痛,均未影响治疗。结论 足三里穴位注射地塞米松治疗恶性肿瘤化疗后骨髓抑制安全、有效,无明显不良反应。
【关键词】足三里穴;地塞米松; 化疗;骨髓抑制
Observation and Nursing on Myelosuppression after Chemotherapy
to Treat M alignant Tumor by Injecting Dexamethasone at St36 Point
ZHENG Yu-Chun,YU Tuo-Ya,DENG Li-Juan
The First People’s Hospital of Liangshan, Liangshan 615000,Cina.
【Abstract】Objective To observe the efficacy and side effects of myelosuppression after chemotherapy to treat m alignant tumor by injecting dexamethasone at st36 point(zu san li).Methods 112 intermeiate and advanced stage m alignant tumor patients who had myelosuppression and Leukocytopenia after chemotherapy were divided into two groups randomly,55 patients were received treatment by injecting dexamethasone at st36 point,and another 57 patients were received subcutaneous injection with recombinant human granulocyte colony-stimulating factor as the control group.To observation on leukocyte restoration and adverse reaction between two groups.Results There were no significant differences in the leukocyte restoration time and efficacy between two groups(P>0.05). Adverse reaction:there was one patient had obviously local distending pain,and abandonedtreatment midway,otheres had no special adverse reaction in the point injection group.There were two patients had general soreness,one had low fever,and one had bone pain in the control group,but had no influence in the treatment.Conclusion Myelosuppression after chemotherapy to treat m alignant tumor by injecting dexamethasone at st36 point was safe,effective,and no significant adverse reaction.
【Key words】St36 point(zu san li); Dexamethasone; Chemotherapy; Myelosuppression; nursing
骨髓抑制是化疗药物常见的毒副反应。我科2006年5月至2008年5月对化疗后出现Ⅰ°～Ⅱ°骨髓抑制白细胞降低的55例患者给予足三里穴位注射地塞米松治疗,效果良好,报告如下。
1 对象与方法
1.1 临床资料 我科住院的112例化疗后出现Ⅰ°～Ⅱ°骨髓抑制的中晚期恶性肿瘤患者,男性58例,女性54例,年龄25~76岁,平均年龄56岁 ......
您现在查看是摘要介绍页，详见PDF附件(1467kb)。